325 related items for PubMed ID: 31573958
1. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
[Abstract] [Full Text] [Related]
2. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
3. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov 25; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
4. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2009 Oct 25; 94(10):3882-8. PubMed ID: 19622620
[Abstract] [Full Text] [Related]
5. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May 25; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
6. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar 25; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
7. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009 Mar 25; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
8. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
Arch Dis Child; 2002 Aug 25; 87(2):139-44. PubMed ID: 12138066
[Abstract] [Full Text] [Related]
9. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Aug 25; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
10. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
Horm Res; 2001 Aug 25; 55(4):161-71. PubMed ID: 11598369
[Abstract] [Full Text] [Related]
11. Long-term Growth in Congenital Adrenal Hyperplasia.
Maheshwari A, Khadilkar V, Gangodkar P, Khadilkar A.
Indian J Pediatr; 2019 Feb 25; 86(2):154-158. PubMed ID: 30097840
[Abstract] [Full Text] [Related]
12. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia.
Ng SM, Stepien KM, Krishan A.
Cochrane Database Syst Rev; 2020 Mar 19; 3(3):CD012517. PubMed ID: 32190901
[Abstract] [Full Text] [Related]
13. Long-term prednisone versus hydrocortisone treatment in children with classic Congenital Adrenal Hyperplasia (CAH) and a brief review of the literature.
Ahmed SEAM, Soliman AT, Ramadan MA, Elawwa A, Abugabal AMS, Emam MHA, De Sanctis V.
Acta Biomed; 2019 Sep 06; 90(3):360-369. PubMed ID: 31580328
[Abstract] [Full Text] [Related]
14. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
J Pediatr Endocrinol Metab; 2006 Mar 06; 19(3):245-51. PubMed ID: 16607925
[Abstract] [Full Text] [Related]
15. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Mar 06; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
16. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
[Abstract] [Full Text] [Related]
17. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan 01; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
18. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
Lemos-Marini SH, Guerra-Júnior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT.
Arq Bras Endocrinol Metabol; 2005 Dec 01; 49(6):902-7. PubMed ID: 16544012
[Abstract] [Full Text] [Related]
19. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
Eur J Endocrinol; 1997 Feb 01; 136(2):188-95. PubMed ID: 9116914
[Abstract] [Full Text] [Related]
20. Growth and development in children with classic congenital adrenal hyperplasia.
Bonfig W.
Curr Opin Endocrinol Diabetes Obes; 2017 Feb 01; 24(1):39-42. PubMed ID: 27898585
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
